Stock Earnings

Question 1

How did GLUE's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Monte Rosa Therapeutics Inc is $-0.33, not beating expectations of $-0.38.

Question 2

How did Monte Rosa Therapeutics Inc GLUE's revenue perform in the last quarter?

Accepted Answer

Monte Rosa Therapeutics Inc revenue for the last quarter is $-0.33

Question 3

What is the revenue estimate for Monte Rosa Therapeutics Inc?

Accepted Answer

According to 9 of Wall street analyst, the revenue estimate of Monte Rosa Therapeutics Inc range from $42.0M to $0.0

Question 4

What's the earning quality score for Monte Rosa Therapeutics Inc?

Accepted Answer

Monte Rosa Therapeutics Inc has a earning quality score of B+/48.508835. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Monte Rosa Therapeutics Inc report earnings?

Accepted Answer

Monte Rosa Therapeutics Inc next earnings report is expected in 2026-02-04

Question 6

What are Monte Rosa Therapeutics Inc's expected earnings?

Accepted Answer

Monte Rosa Therapeutics Inc expected earnings is $5.52M, according to wall-street analysts.

Question 7

Did Monte Rosa Therapeutics Inc beat earnings expectations?

Accepted Answer

Monte Rosa Therapeutics Inc recent earnings of $12.76M does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.38	$-0.33	-13.15%	MISSED
Q2 '25	$-0.39	$-0.15	-61.53%	MISSED
Q1 '25	$-0.34	$0.56	-264.7%	MISSED
Q4 '24	$-0.02	$0.23	-1.25K%	MISSED
Q3 '24	$-0.49	$-0.28	-42.85%	MISSED

Monte Rosa Therapeutics Inc (GLUE) Price

GLUE Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ